Overview
Baxter International Inc. is a global healthcare company based in the United States, primarily engaged in the development, manufacture, and marketing of products that save and sustain the lives of people with chronic and acute medical conditions. Operating in the medical devices and pharmaceuticals sectors, Baxter is known for its innovative treatments in renal care, general and advanced surgery, and acute therapies. Key projects often focus on expanding its renal care portfolio and enhancing patient-centered technologies in infusion and nutritional therapy. The company is active in advancing critical care systems and investing in sustainable solutions aimed at reducing environmental impact. This strategic focus not solely caters to immediate health care needs but also invests in research and development to address evolving medical challenges.
AI+ Ask Fintel’s AI assistant about Baxter International Inc..
Thinking about good questions…
Basic Stats
The Factor Analysis chart (below right) shows a view of Baxter International Inc. from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | |
| EV | |
| Shares Out. | 504.91 MM |
| Earnings Date | |
| EPS (TTM) | |
| Dividend Yield | |
| Ex-Dividend Date | 2025-08-29 |
| Borrow Rate | |
| Short Shares Avail. | 0.00 MM |
| Short Interest | |
| Short Float | |
| Days to Cover | |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | |
| Volatility (1 yr) | |
| Beta | |
| Sharpe Ratio (1 yr) | |
| Sortino Ratio (1 yr) |
| PE Ratio | |
| Price/Book | |
| Price/TBV | |
| Book/Market | |
| EBIT/EV | |
| EBIT(3yr avg)/EV | |
| ROA | |
| ROE | 0.00 |
| ROIC | |
| CROIC | |
| OCROIC | |
| Implied Volatility | |
| Put/Call OI Ratio |
| Growth | |
| Profitability | |
| Quality Score | |
| Value Score | |
| Momentum Score | |
| Stability (Low Vol) Score | |
| Analyst Sentiment | |
| Fund Sentiment | |
| Insider Sentiment | |
| Officer Sentiment | |
| Dividend Score | |
| QVM Score | |
| Piotroski F-SCORE | 0.00 /9 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Baxter International Inc. is MX$580.19. The forecasts range from a low of MX$421.82 to a high of MX$1,038.92. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Baxter International Inc.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2024-08-08 | Goldman Sachs | Neutral | Neutral | Maintains |
| 2024-08-07 | JP Morgan | Neutral | Neutral | Maintains |
| 2024-08-07 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2024-07-15 | Morgan Stanley | Equal-Weight | Underweight | Downgrade |
| 2024-07-10 | Citigroup | Neutral | Neutral | Maintains |
| 2024-07-02 | Evercore ISI Group | Outperform | Outperform | Maintains |
| 2024-05-30 | Goldman Sachs | Neutral | Initiate | |
| 2024-05-22 | Citigroup | Neutral | Neutral | Maintains |
| 2024-05-10 | TD Cowen | Buy | Hold | Downgrade |
| 2024-04-03 | Citigroup | Neutral | Neutral | Maintains |
| 2024-03-05 | B of A Securities | Neutral | Neutral | Maintains |
| 2024-02-12 | Barclays | Overweight | Overweight | Maintains |
| 2024-02-09 | JP Morgan | Neutral | Neutral | Maintains |
| 2023-12-04 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2023-10-31 | JP Morgan | Neutral | Neutral | Maintains |
| 2023-08-21 | Citigroup | Neutral | Neutral | Maintains |
| 2023-08-01 | Barclays | Overweight | Overweight | Maintains |
| 2023-07-31 | Barclays | Overweight | Overweight | Maintains |
| 2023-07-31 | Keybanc | Overweight | Overweight | Maintains |
| 2023-07-28 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2023-07-12 | Stifel | Buy | Buy | Maintains |
| 2023-05-01 | Barclays | Overweight | Maintains | |
| 2023-04-28 | Citigroup | Neutral | Maintains | |
| 2023-04-28 | Deutsche Bank | Hold | Maintains | |
| 2023-04-28 | Stifel | Buy | Maintains | |
| 2023-04-28 | Morgan Stanley | Equal-Weight | Maintains | |
| 2023-04-28 | Keybanc | Overweight | Maintains | |
| 2023-04-04 | Evercore ISI Group | Outperform | Maintains | |
| 2023-03-29 | UBS | Neutral | Initiate | |
| 2023-02-13 | Citigroup | Neutral | Maintains | |
| 2023-02-13 | Barclays | Overweight | Maintains | |
| 2023-02-10 | Wells Fargo | Equal-Weight | Maintains | |
| 2023-02-10 | Cowen & Co. | Outperform | Maintains | |
| 2023-02-10 | Morgan Stanley | Equal-Weight | Maintains | |
| 2023-02-10 | Keybanc | Overweight | Maintains | |
| 2023-02-06 | Keybanc | Overweight | Maintains | |
| 2023-01-09 | Wells Fargo | Equal-Weight | Maintains | |
| 2023-01-06 | Morgan Stanley | Overweight | Equal-Weight | Downgrade |
| 2023-01-05 | Raymond James | Outperform | Market Perform | Downgrade |
| 2023-01-03 | B of A Securities | Buy | Neutral | Downgrade |
| 2022-12-19 | JP Morgan | Overweight | Neutral | Downgrade |
| 2022-12-15 | Deutsche Bank | Buy | Hold | Downgrade |
| 2022-12-15 | Wells Fargo | Equal-Weight | Maintains | |
| 2022-12-12 | Citigroup | Buy | Neutral | Downgrade |
| 2022-11-03 | Goldman Sachs | Sell | Maintains | |
| 2022-10-28 | Raymond James | Outperform | Maintains | |
| 2022-10-28 | Wells Fargo | Equal-Weight | Maintains | |
| 2022-10-28 | Keybanc | Overweight | Maintains | |
| 2022-10-18 | Barclays | Overweight | Initiate | |
| 2022-10-12 | Jefferies | Hold | Initiate | |
| 2022-10-11 | Morgan Stanley | Overweight | Maintains | |
| 2022-08-03 | Goldman Sachs | Sell | Maintains | |
| 2022-07-29 | Raymond James | Outperform | Maintains | |
| 2022-07-29 | Morgan Stanley | Overweight | Maintains | |
| 2022-07-18 | Stifel | Buy | Maintains | |
| 2022-07-15 | Morgan Stanley | Overweight | Maintains | |
| 2022-06-24 | JP Morgan | Overweight | Maintains | |
| 2022-06-24 | Wells Fargo | Overweight | Equal-Weight | Downgrade |
| 2022-05-23 | Morgan Stanley | Overweight | Maintains | |
| 2022-05-17 | Citigroup | Buy | Maintains | |
| 2022-04-29 | Morgan Stanley | Overweight | Maintains | |
| 2022-04-29 | Raymond James | Outperform | Maintains | |
| 2022-04-29 | Wells Fargo | Overweight | Maintains | |
| 2022-04-29 | Keybanc | Overweight | Maintains | |
| 2022-04-04 | Goldman Sachs | Neutral | Sell | Downgrade |
| 2022-02-18 | Morgan Stanley | Overweight | Maintains | |
| 2022-02-18 | Raymond James | Outperform | Maintains | |
| 2022-02-18 | Keybanc | Overweight | Maintains | |
| 2022-01-07 | Morgan Stanley | Equal-Weight | Overweight | Upgrade |
| 2022-01-04 | Raymond James | Outperform | Maintains | |
| 2022-01-04 | Keybanc | Overweight | Maintains | |
| 2021-10-29 | Morgan Stanley | Equal-Weight | Maintains | |
| 2021-09-13 | Cowen & Co. | Market Perform | Outperform | Upgrade |
| 2021-09-03 | Barclays | Equal-Weight | Overweight | Upgrade |
| 2021-08-03 | Goldman Sachs | Neutral | Maintains | |
| 2021-08-02 | Keybanc | Overweight | Maintains | |
| 2021-05-25 | Barclays | Equal-Weight | Initiate | |
| 2021-04-30 | Citigroup | Buy | Maintains | |
| 2021-02-05 | Credit Suisse | Outperform | Maintains | |
| 2021-02-05 | Raymond James | Outperform | Maintains | |
| 2021-01-29 | Piper Sandler | Overweight | Neutral | Downgrade |
| 2020-12-15 | Morgan Stanley | Equal-Weight | Maintains | |
| 2020-11-02 | Stifel | Buy | Maintains | |
| 2020-10-30 | Morgan Stanley | Equal-Weight | Maintains | |
| 2020-10-30 | KeyBanc | Overweight | Maintains | |
| 2020-10-12 | Raymond James | Outperform | Maintains | |
| 2020-10-09 | UBS | Buy | Maintains | |
| 2020-10-01 | Citigroup | Neutral | Buy | Upgrade |
| 2020-09-04 | Argus Research | Buy | Hold | Downgrade |
| 2020-07-31 | Morgan Stanley | Equal-Weight | Maintains | |
| 2020-07-31 | Raymond James | Outperform | Maintains | |
| 2020-06-24 | Oppenheimer | Outperform | Initiate | |
| 2020-05-01 | UBS | Buy | Maintains | |
| 2020-05-01 | Credit Suisse | Outperform | Maintains | |
| 2020-05-01 | SVB Leerink | Outperform | Maintains | |
| 2020-05-01 | KeyBanc | Overweight | Maintains | |
| 2020-04-28 | JP Morgan | Overweight | Maintains | |
| 2020-04-13 | Raymond James | Outperform | Maintains | |
| 2020-03-27 | Morgan Stanley | Equal-Weight | Maintains | |
| 2020-03-19 | Stifel | Hold | Buy | Upgrade |
| 2020-03-18 | Credit Suisse | Outperform | Maintains | |
| 2020-03-18 | Citigroup | Neutral | Maintains | |
| 2020-03-18 | Deutsche Bank | Buy | Maintains | |
| 2020-03-18 | Raymond James | Outperform | Maintains | |
| 2020-03-18 | KeyBanc | Sector Weight | Overweight | Upgrade |
| 2020-03-06 | Credit Suisse | Outperform | Maintains | |
| 2020-03-05 | Citigroup | Neutral | Initiate | |
| 2020-02-14 | Wells Fargo | Overweight | Maintains | |
| 2020-02-13 | Goldman Sachs | Buy | Initiate | |
| 2020-02-06 | CFRA | Hold | Maintains | |
| 2020-01-16 | Wells Fargo | Overweight | Maintains | |
| 2020-01-02 | Evercore ISI Group | In-Line | Outperform | Upgrade |
| 2019-12-20 | JP Morgan | Overweight | Maintains | |
| 2019-12-17 | Morgan Stanley | Overweight | Equal-Weight | Downgrade |
| 2019-10-28 | UBS | Buy | Maintains | |
| 2019-07-26 | Credit Suisse | Outperform | Maintains | |
| 2019-06-26 | Wells Fargo | Outperform | Maintains | |
| 2019-06-26 | KeyBanc | Sector Weight | Initiate | |
| 2019-04-15 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2019-04-08 | Evercore ISI Group | Outperform | In-Line | Downgrade |
| 2019-04-03 | Wells Fargo | Outperform | Outperform | Maintains |
| 2019-03-05 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2019-02-01 | Barclays | Underweight | Equal-Weight | Upgrade |
| 2019-01-02 | Citigroup | Neutral | Buy | Upgrade |
| 2019-01-02 | Morgan Stanley | Equal-Weight | Overweight | Upgrade |
| 2018-12-18 | Credit Suisse | Outperform | Initiate | |
| 2018-12-04 | Wells Fargo | Outperform | Outperform | Maintains |
| 2018-11-28 | UBS | Buy | Initiate | |
| 2018-11-13 | Citigroup | Neutral | Neutral | Maintains |
| 2018-11-08 | RBC Capital | Sector Perform | Sector Perform | Maintains |
| 2018-11-05 | Morgan Stanley | Underweight | Underweight | Maintains |
| 2018-11-02 | Argus | Hold | Buy | Upgrade |
| 2018-11-01 | Wells Fargo | Outperform | Outperform | Maintains |
| 2018-11-01 | BMO Capital | Outperform | Outperform | Maintains |
| 2018-11-01 | Leerink Swann | Outperform | Outperform | Maintains |
| 2018-11-01 | Raymond James | Outperform | Outperform | Maintains |
| 2018-10-16 | Barclays | Underweight | Initiate | |
| 2018-10-11 | Morgan Stanley | Underweight | Underweight | Maintains |
| 2018-07-31 | Citigroup | Neutral | Neutral | Maintains |
| 2018-07-27 | JP Morgan | Overweight | Overweight | Maintains |
| 2018-07-27 | PiperJaffray | Overweight | Overweight | Maintains |
| 2018-05-22 | Bank of America | Buy | Buy | Maintains |
| 2018-04-30 | Stifel Nicolaus | Hold | Hold | Maintains |
| 2018-04-30 | Citigroup | Neutral | Neutral | Maintains |
| 2018-02-06 | Citigroup | Neutral | Neutral | Maintains |
| 2018-02-02 | Barclays | Overweight | Overweight | Maintains |
| 2018-02-02 | BMO Capital | Outperform | Outperform | Maintains |
| 2018-01-03 | Evercore ISI Group | Outperform | Initiate | |
| 2018-01-03 | Raymond James | Market Perform | Outperform | Upgrade |
| 2018-01-02 | Bank of America | Neutral | Buy | Upgrade |
| 2018-01-02 | JP Morgan | Neutral | Overweight | Upgrade |
| 2017-10-26 | Barclays | Overweight | Maintains | |
| 2017-10-26 | Morgan Stanley | Equal-Weight | Maintains | |
| 2017-08-17 | Citigroup | Neutral | Initiate | |
| 2017-07-27 | Barclays | Overweight | Maintains | |
| 2017-07-25 | Morgan Stanley | Equal-Weight | Maintains | |
| 2017-07-11 | BMO Capital | Market Perform | Outperform | Upgrade |
| 2017-06-30 | Cantor Fitzgerald | Overweight | Initiate | |
| 2017-05-16 | Goldman Sachs | Buy | Initiate | |
| 2016-10-13 | Wells Fargo | Outperform | Initiate | |
| 2016-09-15 | Barclays | Overweight | Initiate | |
| 2016-07-28 | UBS | Neutral | Maintains | |
| 2016-07-27 | JP Morgan | Neutral | Maintains | |
| 2016-05-04 | Evercore ISI Group | Buy | Initiate | |
| 2016-04-25 | Credit Suisse | Neutral | Maintains | |
| 2016-04-14 | PiperJaffray | Neutral | Overweight | Upgrade |
| 2016-02-03 | BMO Capital | Market Perform | Maintains | |
| 2015-10-28 | Leerink Swann | Market Perform | Maintains | |
| 2015-08-11 | Barclays | Overweight | Maintains | |
| 2015-07-30 | Leerink Swann | Outperform | Market Perform | Downgrade |
| 2015-07-13 | Deutsche Bank | Hold | Maintains | |
| 2015-07-07 | BMO Capital | Outperform | Market Perform | Downgrade |
| 2015-07-02 | Bank of America | Buy | Neutral | Downgrade |
| 2015-07-02 | Barclays | Overweight | Maintains | |
| 2015-06-24 | Goldman Sachs | Buy | Initiate | |
| 2015-05-19 | Barclays | Overweight | Maintains | |
| 2015-04-24 | BMO Capital | Outperform | Maintains | |
| 2015-04-20 | JP Morgan | Neutral | Maintains | |
| 2015-02-18 | JP Morgan | Neutral | Maintains | |
| 2014-10-17 | Barclays | Overweight | Maintains | |
| 2014-10-17 | Credit Suisse | Outperform | Maintains | |
| 2014-10-13 | Morgan Stanley | Equal-Weight | Maintains | |
| 2014-10-06 | Bank of America | Buy | Maintains | |
| 2014-09-17 | JP Morgan | Neutral | Maintains | |
| 2014-07-18 | JP Morgan | Neutral | Maintains | |
| 2014-07-15 | Barclays | Overweight | Maintains | |
| 2014-03-17 | Goldman Sachs | Buy | Maintains | |
| 2014-01-27 | Citigroup | Neutral | Maintains | |
| 2014-01-24 | BMO Capital | Outperform | Maintains | |
| 2014-01-24 | Deutsche Bank | Hold | Maintains | |
| 2014-01-07 | RBC Capital | Outperform | Sector Perform | Downgrade |
| 2013-11-18 | Credit Suisse | Neutral | Outperform | Upgrade |
| 2013-10-23 | Cowen & Co. | Outperform | Market Perform | Downgrade |
| 2013-10-18 | Raymond James | Outperform | Market Perform | Downgrade |
| 2013-10-18 | Morgan Stanley | Overweight | Equal-weight | Downgrade |
| 2013-10-02 | Credit Suisse | Outperform | Neutral | Downgrade |
| 2013-09-04 | CL King | Neutral | Buy | Upgrade |
| 2013-07-10 | Credit Suisse | Outperform | Initiate | |
| 2013-05-16 | Bank of America | Buy | Maintains | |
| 2013-05-14 | Morgan Stanley | Overweight | Maintains | |
| 2013-05-07 | Barclays | Equal-Weight | Overweight | Upgrade |
| 2013-04-15 | PiperJaffray | Overweight | Maintains | |
| 2013-04-12 | Deutsche Bank | Hold | Maintains | |
| 2013-03-25 | Morgan Stanley | Overweight | Maintains | |
| 2013-01-04 | Deutsche Bank | Hold | Maintains | |
| 2012-12-20 | Morgan Stanley | Overweight | Maintains | |
| 2012-11-27 | Mizuho | Buy | Neutral | Downgrade |
| 2012-11-26 | JP Morgan | Overweight | Maintains | |
| 2012-11-26 | Bank of America | Buy | Maintains | |
| 2012-11-20 | Stifel Nicolaus | Hold | Initiate | |
| 2012-11-15 | Barclays | Equal-Weight | Maintains | |
| 2012-10-11 | PiperJaffray | Overweight | Maintains | |
| 2012-10-10 | Citigroup | Neutral | Maintains | |
| 2012-10-01 | JP Morgan | Overweight | Maintains | |
| 2012-09-24 | Deutsche Bank | Buy | Hold | Downgrade |
| 2012-09-19 | BMO Capital | Outperform | Initiate | |
| 2012-07-25 | Goldman Sachs | Buy | Maintains | |
| 2012-07-20 | Deutsche Bank | Buy | Maintains | |
| 2012-07-09 | Citigroup | Neutral | Maintains | |
| 2012-04-20 | Citigroup | Neutral | Maintains | |
| 2012-04-20 | UBS | Buy | Maintains | |
| 2012-04-20 | Deutsche Bank | Buy | Maintains | |
| 2012-03-20 | Morgan Stanley | Overweight | Maintains | |
| 2012-03-05 | Dougherty | Neutral | Maintains | |
| 2012-02-28 | UBS | Buy | Maintains | |
| 2025-07-15 | Morgan Stanley | Underweight | Underweight | Maintains |
| 2025-07-08 | Evercore ISI Group | Outperform | Outperform | Maintains |
| 2024-12-11 | Citigroup | Neutral | Neutral | Maintains |
| 2025-05-02 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2024-10-01 | Citigroup | Neutral | Neutral | Maintains |
| 2025-02-26 | Goldman Sachs | Buy | Reiterate | |
| 2025-02-21 | JP Morgan | Neutral | Neutral | Maintains |
| 2025-02-20 | Barclays | Overweight | Reiterate | |
| 2025-03-10 | Barclays | Overweight | Overweight | Maintains |
| 2024-11-11 | Stifel | Buy | Buy | Maintains |
| 2025-05-05 | Morgan Stanley | Underweight | Underweight | Maintains |
| 2025-08-04 | Barclays | Overweight | Overweight | Maintains |
| 2025-08-04 | Stifel | Buy | Hold | Downgrade |
| 2025-07-09 | Citigroup | Neutral | Neutral | Maintains |
| 2025-08-01 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2025-08-04 | UBS | Neutral | Neutral | Maintains |
